Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG) - Institut Paoli-Calmettes Access content directly
Journal Articles Gynecologic Oncology Year : 2022

Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)

Abstract

Since 2010, the network of rare malignant tumors of the ovary (TMRG) was developed to optimize the management of patients, also allowing a histological second opinion of rare ovarian tumors. The aim of this work was to study the contribution of second opinion to improve histological diagnostic accuracy on ovarian rare malignant tumors included in the TMRG database.
Fichier principal
Vignette du fichier
S0090825822002013.pdf (215.83 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03857604 , version 1 (22-07-2024)

Licence

Identifiers

Cite

S. Henno, C. Jeanne, T de la Motte Rouge, C. Genestie, I. Treilleux, et al.. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG). Gynecologic Oncology, 2022, 165 (3), pp.637-641. ⟨10.1016/j.ygyno.2022.03.019⟩. ⟨hal-03857604⟩
103 View
8 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More